25
Participants
Start Date
April 21, 2015
Primary Completion Date
September 14, 2018
Study Completion Date
February 10, 2022
Copanlisib (BAY80-6946)
Dosing is weekly for the first 3 weeks (on Days 1, 8, and 15) of a 28-day cycle, followed by a 1-week break (i.e., no infusion on Day 22).
Nagoya
Nagoya
Nagoya
Nagoya
Nagoya
Maebashi
Kobe
Sendai
Chuo-ku
Koto-ku
Fukuoka
Fukuoka
Kyoto
Lead Sponsor
Bayer
INDUSTRY